Cardioprotective Effects of Subcutaneous Ebselen against Daunorubicin‐Induced Cardiomyopathy in Rats
Authors:
- 27 November 2006
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 99 (6) , 412-417
Abstract
Daunorubicin is an anthracycline antitumour agent that can cause severe cardiomyopathy leading to a frequently fatal congestive heart failure. Although the exact molecular mechanisms of cardiotoxicity are not well established, oxidative mechanisms involving daunorubicin‐induced superoxide anion production have been proposed. In the present study, we showed that ebselen a seleno‐organic compound exhibiting glutathione peroxidase‐like and antioxidant activities, significantly ameliorated daunorubicin‐induced cardiomyopathy. Subcutaneous administration of ebselen to daunorubicin‐treated rats showed significant improvement in serum cardiac indices including creatine kinase isoenzyme and lactate dehydrogenase as well as serum glutathione (GSH) peroxidase. Moreover, myocardium of daunorubicin/ebselen‐treated rats showed significant improvement in daunorubicin‐induced depletion of GSH peroxidase activity and reduced glutathione content, in addition to attenuation of daunorubicin‐induced increase in cardiac malondialdehyde production and total nitrate/nitrite concentration levels. These results were confirmed by histopathological examination of ventricles of daunorubicin/ebselen‐treated rats that revealed significant improvement of the characteristic cardiomyopathic changes induced by daunorubicin treatment. Interestingly, control rats treated with ebselen showed significant elevation in serum lactate dehydrogenase activity, cardiac malondialdehyde production and total nitrate/nitrite concentration levels compared with the untreated control animals. In conclusion, ebselen treatment significantly alleviates daunorubicin‐induced cardiomyopathy.Keywords
This publication has 37 references indexed in Scilit:
- Nitrosative stress and pharmacological modulation of heart failureTrends in Pharmacological Sciences, 2005
- Investigations of Calsequestrin as a Target for Anthracyclines: Comparison of Functional Effects of Daunorubicin, Daunorubicinol, and TrifluoperazineMolecular Pharmacology, 2005
- Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbitsPharmacological Research, 2005
- Inhibition study of rabbit liver cytosolic reductases involved in daunorubicin toxicationJournal of Enzyme Inhibition and Medicinal Chemistry, 2005
- Ebselen inhibits NO‐induced apoptosis of differentiated PC12 cells via inhibition of ASK1‐p38 MAPK‐p53 and JNK signaling and activation of p44/42 MAPK and Bcl‐2Journal of Neurochemistry, 2003
- Selenium-containing compounds attenuate peroxynitrite-mediated NF-κB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytesFree Radical Biology and Medicine, 2003
- Induction of cellular necrosis by the glutathione peroxidase mimetic ebselenJournal of Cellular Biochemistry, 2003
- Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxideBiochemical Journal, 2002
- The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in ratsPharmacological Research, 2001
- Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxideFEBS Letters, 1994